We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCA icon
126
HCA Healthcare
HCA
$89.5B
$334K ﹤0.01%
1,000
-19,900
-95% -$6.08M
AXSM icon
127
Axsome Therapeutics
AXSM
$10.9B
$319K ﹤0.01%
4,000
ALNY icon
128
Alnylam Pharmaceuticals
ALNY
$29.3B
$299K ﹤0.01%
2,000
ACLX
129
DELISTED
Arcellx
ACLX
$278K ﹤0.01%
4,000
CHE icon
130
Chemed
CHE
$7.22B
$257K ﹤0.01%
400
EHC icon
131
Encompass Health
EHC
$12.4B
$248K ﹤0.01%
3,000
SWTX
132
DELISTED
SpringWorks Therapeutics
SWTX
$246K ﹤0.01%
+5,000
New +$231K
GKOS icon
133
Glaukos
GKOS
$10.6B
$245K ﹤0.01%
2,600
BTSG icon
134
BrightSpring Health Services
BTSG
$12.4B
$239K ﹤0.01%
+22,000
New +$220K
SNDX icon
135
Syndax Pharmaceuticals
SNDX
$1.82B
$238K ﹤0.01%
10,000
CRNX icon
136
Crinetics Pharmaceuticals
CRNX
$8.92B
$234K ﹤0.01%
5,000
-117,904
-96% -$4.61M
ALPN
137
DELISTED
Alpine Immune Sciences Inc
ALPN
$234K ﹤0.01%
+5,900
New +$174K
CCCC icon
138
C4 Therapeutics
CCCC
$412M
$229K ﹤0.01%
+28,000
New +$217K
HQY icon
139
HealthEquity
HQY
$8.75B
$229K ﹤0.01%
+2,800
New +$219K
MMSI icon
140
Merit Medical Systems
MMSI
$5.32B
$227K ﹤0.01%
+3,000
New +$232K
ACHC icon
141
Acadia Healthcare
ACHC
$2.94B
$222K ﹤0.01%
2,800
IDYA icon
142
IDEAYA Biosciences
IDYA
$3.56B
$219K ﹤0.01%
+5,000
New +$215K
SBRA icon
143
Sabra Healthcare REIT
SBRA
$5.37B
$207K ﹤0.01%
14,000
RCM
144
DELISTED
R1 RCM Inc. Common Stock
RCM
$206K ﹤0.01%
16,000
FOLD
145
DELISTED
Amicus Therapeutics
FOLD
$188K ﹤0.01%
16,000
GRFS
146
Grifois
GRFS
$5.4B
$187K ﹤0.01%
+28,000
New +$219K
ARDX icon
147
Ardelyx
ARDX
$997M
$168K ﹤0.01%
+23,000
New +$197K
OSCR icon
148
Oscar Health
OSCR
$8.61B
$164K ﹤0.01%
+11,000
New +$151K
SCRMW
149
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$157K ﹤0.01%
333,330
BYND icon
150
Beyond Meat
BYND
$277M
$157K ﹤0.01%
+19,000
New +$146K

Similar funds

Farallon Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Farallon Capital Management held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Farallon Capital Management's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Farallon Capital Management added most to Hess in Q1 2024, an estimated $502M increase.
  • Farallon Capital Management's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Farallon Capital Management fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Farallon Capital Management opened 43 new positions and closed 21 in Q1 2024.
  • Farallon Capital Management's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.